790 reports of this reaction
2.1% of all PHENYTOIN reports
#7 most reported adverse reaction
STATUS EPILEPTICUS is the #7 most commonly reported adverse reaction for PHENYTOIN, manufactured by Viatris Specialty LLC. There are 790 FDA adverse event reports linking PHENYTOIN to STATUS EPILEPTICUS. This represents approximately 2.1% of all 36,996 adverse event reports for this drug.
Patients taking PHENYTOIN who experience status epilepticus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
STATUS EPILEPTICUS is a less commonly reported adverse event for PHENYTOIN, but still significant enough to appear in the safety profile.
In addition to status epilepticus, the following adverse reactions have been reported for PHENYTOIN:
The following drugs have also been linked to status epilepticus in FDA adverse event reports:
STATUS EPILEPTICUS has been reported as an adverse event in 790 FDA reports for PHENYTOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
STATUS EPILEPTICUS accounts for approximately 2.1% of all adverse event reports for PHENYTOIN, making it a notable side effect.
If you experience status epilepticus while taking PHENYTOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.